((2S,4R)-4,6-dihydroxytetrahydro-2H-py ran-2-yl)methyl carboxylate and process for the production employing a 2-deoxyribose-5-phosphate aldolase

Details for Australian Patent Application No. 2009207721 (hide)

Owner Lek Pharmaceuticals d.d.

Inventors Mrak, Peter; Cluzeau, Jerome; Casar, Zdenko; Oslaj, Matej; Kopitar, Gregor

Agent Griffith Hack

Pub. Number AU-A-2009207721

PCT Pub. Number WO2009/092702

Priority 08100845.0 23.01.08 EP

Filing date 20 January 2009

Wipo publication date 30 July 2009

International Classifications

C12P 17/06 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms

C07C 67/00 (2006.01) Preparation of carboxylic acid esters

C07D 239/00 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 309/00 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/092702 Priority application(s): WO2009/092702

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009207722-Method for lyophilising particles having a pharmaceutical compound contained therein and a pharmaceutical pack containing such particles

2009207719-Coloured polypropylene composition having a high content of betamodification